| Thomas C Fairbank, PHD | |
|
2084 N 1700 W Ste 6, Layton, UT 84041 | |
| (801) 773-7177 | |
| Not Available |
| Full Name | Thomas C Fairbank |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 2084 N 1700 W Ste 6, Layton, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194709980 | NPI | - | NPPES |
| 870465986000 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 109352-2501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Thomas C Fairbank, PHD 1767 N 2525 E, Layton, UT 84040 Ph: (801) 546-9515 | Thomas C Fairbank, PHD 2084 N 1700 W Ste 6, Layton, UT 84041 Ph: (801) 773-7177 |
News Archive
Breastfeeding is known to provide significant health benefits for both infants and their mothers. However, while many women intend to breastfeed despite returning to work, a new study finds that mothers who plan to breastfeed for at least three months but return to work full-time are less likely to meet their breastfeeding goals.
In the September issue of the Journal of Clinical Investigation, researchers at MD Anderson Cancer Center report that ovarian cancer cells activate the HOXA9 gene to compel stromal cells to create an environment that supports tumor growth.
There is high variability in access to, and quality of, bone density scanning facilities worldwide, according to a landmark global study carried out at the Medical Research Council Lifecourse Epidemiology Unit in collaboration with the International Osteoporosis Foundation and the International Society for Clinical Densitometry.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's: Committee for Medicinal Products for Human Use has adopted a positive opinion for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.
One of the difficulties of fighting cancer is that drugs often hit other non-cancerous cells, causing patients to get sick. But what if researchers could sneak cancer-fighting particles into just the cancer cells?
› Verified 5 days ago
Dr. Scott W. Boyle, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 | |
Jennifer Guthmann, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 327 W Gordon Ave Ste 2, Layton, UT 84041 Phone: 801-683-1062 Fax: 801-295-5537 | |
Gordon L Day, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1207 E 3125 N, Layton, UT 84040 Phone: 801-897-3957 | |
Miss Kady Jo Coombs, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2940 N Church St Ste 303, Layton, UT 84040 Phone: 801-593-4171 | |
Dr. Trevor Taylor, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Todd A Soutor, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 |